Table 1. General design scheme of the study.
Visit I | Visit II | Visit III |
n=6 PLB Intraparenchymal introduction of BMSC |
n=6 Treatment at the out-patient department Dynamic evaluation within 5 months |
n=6 Evaluation of therapeutic results; 6th month PLB |